FDA expected to evaluate Wockhardt plant; GSK starts a Twitter account for plant progress

> Watson-Marlow Pumps Group has acquired for £8.5 million another U.K.-based company, Bio Pure Technology, which makes single-use tubing connector systems for the biopharmaceutical industry. Report

> Nanyang Polytechnic in Singapore, in a partnership with GlaxoSmithKline ($GSK), will train 400 students annually in pharmaceutical manufacturing. Report

> The FDA is expected this month to inspect Wockhardt's plant in Shendra where it could shift production from banned plants. Report

> Baudette, MN-based ANI Pharmaceuticals has a new contract to produce a generic drug for Sterling Pharmaceutical Services. Release

And finally... GlaxoSmithKline has launched a new website and Twitter account dedicated to keeping the public informed about the progress of the £350 million ($574 million) biopharmaceutical plant it is building in Ulverston, U.K. Announcement

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.